rs878855083

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_024306.5(FA2H):​c.821_822delCT​(p.Pro274ArgfsTer38) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,446,280 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

FA2H
NM_024306.5 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 9.95

Publications

0 publications found
Variant links:
Genes affected
FA2H (HGNC:21197): (fatty acid 2-hydroxylase) This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010]
FA2H Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 35
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-74716563-CAG-C is Pathogenic according to our data. Variant chr16-74716563-CAG-C is described in ClinVar as Pathogenic. ClinVar VariationId is 241466.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FA2HNM_024306.5 linkc.821_822delCT p.Pro274ArgfsTer38 frameshift_variant Exon 6 of 7 ENST00000219368.8 NP_077282.3 Q7L5A8-1
FA2HXM_011523319.3 linkc.581_582delCT p.Pro194ArgfsTer38 frameshift_variant Exon 6 of 7 XP_011521621.1
FA2HXM_011523317.4 linkc.*1685_*1686delCT 3_prime_UTR_variant Exon 6 of 6 XP_011521619.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FA2HENST00000219368.8 linkc.821_822delCT p.Pro274ArgfsTer38 frameshift_variant Exon 6 of 7 1 NM_024306.5 ENSP00000219368.3 Q7L5A8-1
FA2HENST00000562145.1 linkn.542_543delCT non_coding_transcript_exon_variant Exon 1 of 2 1
FA2HENST00000567683.5 linkn.*100_*101delCT non_coding_transcript_exon_variant Exon 4 of 5 2 ENSP00000455126.1 H3BP32
FA2HENST00000567683.5 linkn.*100_*101delCT 3_prime_UTR_variant Exon 4 of 5 2 ENSP00000455126.1 H3BP32

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD2 exomes
AF:
0.00000469
AC:
1
AN:
213276
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000328
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000138
AC:
2
AN:
1446280
Hom.:
0
AF XY:
0.00000139
AC XY:
1
AN XY:
718178
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33198
American (AMR)
AF:
0.0000240
AC:
1
AN:
41742
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25786
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39032
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84606
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51650
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5744
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1104712
Other (OTH)
AF:
0.0000167
AC:
1
AN:
59810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Spastic paraplegia Pathogenic:1
Jun 15, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 241466). This variant has not been reported in the literature in individuals affected with FA2H-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Pro274Argfs*38) in the FA2H gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FA2H are known to be pathogenic (PMID: 20853438, 25496456, 25732363, 26344562). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
9.9
Mutation Taster
=10/190
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878855083; hg19: chr16-74750461; API